Biolase, Inc. (BIOL) stock prices updated...
 

Biolase, Inc. stock price

Biolase, Inc. latest news:


  • 08/07/2017 14:16:37

    BRIEF-BIOLASE Q2 loss per share $0.06

    * Q2 revenue $12.6 million versus $13.8 million Source text for Eikon: Further company coverage:

  • More trends:

    BioLife Solutions, Inc.BLFS | BioLineRx Ltd.BLRX | BioMarin Pharmaceutical Inc.BMRN | BiondVax Pharmaceuticals Ltd.BVXV | BiondVax Pharmaceuticals Ltd.BVXVW | Bio-Path Holdings, Inc.BPTH | BioScrip, Inc.BIOS | BioShares Biotechnology Clinical Trials FundBBC | BioShares Biotechnology Products FundBBP | BioSpecifics Technologies CorpBSTC |